Premium
Response to recent commentaries regarding the involvement of a ngiotensin‐converting enzyme 2 ( ACE2 ) and renin‐angiotensin system blockers in SARS‐CoV ‐2 infections
Author(s) -
Speth Robert C.
Publication year - 2020
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.21672
Subject(s) - renin–angiotensin system , angiotensin converting enzyme 2 , peptidyl dipeptidase a , enzyme , pharmacology , covid-19 , chemistry , medicine , endocrinology , biochemistry , blood pressure , disease , infectious disease (medical specialty)